SELENON (SEPN1) protects skeletal muscle from saturated fatty acid-induced ER stress and insulin resistance

Redox Biol. 2019 Jun:24:101176. doi: 10.1016/j.redox.2019.101176. Epub 2019 Mar 23.

Abstract

Selenoprotein N (SELENON) is an endoplasmic reticulum (ER) protein whose loss of function leads to a congenital myopathy associated with insulin resistance (SEPN1-related myopathy). The exact cause of the insulin resistance in patients with SELENON loss of function is not known. Skeletal muscle is the main contributor to insulin-mediated glucose uptake, and a defect in this muscle-related mechanism triggers insulin resistance and glucose intolerance. We have studied the chain of events that connect the loss of SELENON with defects in insulin-mediated glucose uptake in muscle cells and the effects of this on muscle performance. Here, we show that saturated fatty acids are more lipotoxic in SELENON-devoid cells, and blunt the insulin-mediated glucose uptake of SELENON-devoid myotubes by increasing ER stress and mounting a maladaptive ER stress response. Furthermore, the hind limb skeletal muscles of SELENON KO mice fed a high-fat diet mirrors the features of saturated fatty acid-treated myotubes, and show signs of myopathy with a compromised force production. These findings suggest that the absence of SELENON together with a high-fat dietary regimen increases susceptibility to insulin resistance by triggering a chronic ER stress in skeletal muscle and muscle weakness. Importantly, our findings suggest that environmental cues eliciting ER stress in skeletal muscle (such as a high-fat diet) affect the pathological phenotype of SEPN1-related myopathy and can therefore contribute to the assessment of prognosis beyond simple genotype-phenotype correlations.

Keywords: Congenital myopathies; ER stress response; Insulin resistance; SELENON; SEPN1.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Endoplasmic Reticulum / metabolism
  • Endoplasmic Reticulum Stress* / drug effects
  • Fatty Acids / metabolism*
  • Fatty Acids / pharmacology
  • Female
  • Glucose / metabolism
  • Insulin / metabolism
  • Insulin Resistance*
  • Male
  • Mice
  • Mice, Knockout
  • Mitochondria / drug effects
  • Mitochondria / metabolism
  • Muscle Proteins / genetics*
  • Muscle, Skeletal / metabolism*
  • Muscular Diseases / etiology
  • Muscular Diseases / metabolism
  • Muscular Diseases / pathology
  • Palmitates / pharmacology
  • Phenotype
  • Selenoproteins / genetics*
  • Signal Transduction

Substances

  • Fatty Acids
  • Insulin
  • Muscle Proteins
  • Palmitates
  • SELENON protein, human
  • Selenoproteins
  • Glucose